Recognizing First Progression in Gastric Cancers

 

S

Targeted and Novel Therapy in HER2+ Advanced Gastric Cancer: Efficacy Data on T-DXd vs. Chemotherapy, 1L Pembro / Trastuzumab / CAPEOX

By Shagufta Shaheen 2 Videos
144 views
April 13, 2021
0 Comments
Login to view comments. Click here to Login
Recognizing First Progression in Gastric Cancers
23:25
2nd Annual International Gastric Cancer Educational Symposium

Nutrition Care in Patients With GC: Recommendations During and After…

Feat. R. Lopez
24:50
UChicago Medicine

Optimizing 2/3L Therapy for GE Adenocarcinoma: RAINBOW Paclitaxel/Ra…

Feat. D. Catenacci
20:40
2nd Annual International Gastric Cancer Educational Symposium

Optimization of Perioperative Gastric Cancer Care: What Are the Outc…

Feat. A. Nagarajan
12:23
Afsaneh Barzi

RAINBOW & REGARD Trial Data on Gastric Cancer: The Impact of 2L …

16:00
2nd Annual International Gastric Cancer Educational Symposium

Genetic Testing in Gastric Cancer: How to Recognize Hereditary Cance…

Feat. S. Rhode
09:58
2020 ASCO Virtual Direct™ Highlights

Updates on Advanced GE Cancers: 2L FOLFIRI + Ramucirumab vs. Paclita…

Feat. D. Catenacci
13:08
Gastroesophageal Cancer Educational Symposium

Prevention and Detection of Gastric Cancer: How Can We Detect It Ear…

Feat. A. Chan
09:03
Geoffrey Ku

Gastric Cancer Management: Why Is It Important to Actively Treat? Ho…

05:07
Zev A. Wainberg

Efficacy Data From RAINBOW Trial on Advanced Gastric Cancer: The Eff…

06:38
ESO Eastern Europe and Balkan Region Refresher Course on Gastrointestinal Cancer

New Standard for 2nd Line Therapy in Metastatic Gastric Cancer: VEGF…

Feat. T. Omrcen
29:08
Gastroesophageal Cancer Educational Symposium

Nutrition Considerations for Gastroesophageal Cancer: Goals, How the…

Feat. A. Draviam
22:53
2nd Annual International Gastric Cancer Educational Symposium

Managing Hereditary Diffuse Gastric Cancer: Is Prophylactic Gastrect…

Feat. M. Burch
24:28
2nd Annual International Gastric Cancer Educational Symposium

Integrative Medicine for GC: What Is Integrative Oncology, and How t…

Feat. M. Cusnir
12:10
Shagufta Shaheen

Targeted and Novel Therapy in HER2+ Advanced Gastric Cancer: Efficac…

18:17
Shagufta Shaheen

2021 Update on HER2- Gastric Cancer: 1L Chemo + Nivo, Bemarituzumab …

11:02
Moffitt Cancer Center

Utilization of ctDNA NGS Analysis in Stage IV Cancers: PANGEA Strate…

Feat. D. Catenacci
21:00
Raul Gonzalez

Pathologist's Perspective on Targeted Therapies in Advanced Gas…

05:12
Bassel El-Rayes

Improving Survival in Advanced HER2+/- Gastric Cancer: Considering 2…

08:35
Fox Chase Cancer Center

2L Treatment of Advanced Gastric Cancer: Moving Towards an Opportuni…

Feat. N. Vijayvergia
14:38
10th Annual Winship Cancer Institute Gastrointestinal Cancer Virtual Symposium

Recent IO Data in GEJ or Gastric Cancers: Are We There Yet?

Feat. O. Alese
09:20
2021 KUMC Virtual Multidisciplinary Oncology Review

Targeted Therapy in Advanced GE/GEJ Cancer: T-DXd, mFOLFOX6+/-1L Bem…

Feat. A. Saeed
07:44
Memorial Sloan Kettering Cancer Center

ESMO 2021 Abstract Review on Genomic Landscape of Late-Stage Gastric…

Feat. Y. Y. Janjigian
22:59
Mayo Clinic & DDF Gastroesophageal Cancer Educational Symposium

Understanding Genetic and Environmental Risk Factors in Gastroesopha…

Feat. L. Boardman
08:20
Massachusetts General Hospital Cancer Center

ESMO 2021 Updates on 1L DKN-01 + Tislelizumab & Chemotherapy in …

Feat. S. Klempner